Please select the option that best describes you:
When considering cytoreductive nephrectomy in metastatic kidney cancer, in which situations would you consider nephron-sparing approaches such as partial nephrectomy or SBRT?
How do you balance the therapeutic efficacy of CN with long-term CKD risk from radical nephrectomy?
Answer from: Medical Oncologist at Community Practice
Nephron-sparing strategies (partial nephrectomy or stereotactic radiation therapy are reserved for patients with limited disease, favorable anatomy, or contraindications to surgery, where the goal is to maximize oncologic control while preserving renal function and minimizing morbidity. Careful...
Sign In or Register to read more